Clinical Trials in Mississippi

Mississippi is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Mississippi and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 60 actively recruiting studies with Mississippi sites out of 60 registered in total. The busiest research areas in Mississippi are Obesity, Overweight, Acute Myeloid Leukemia. Leading sponsors running trials in the state include SWOG Cancer Research Network, National Cancer Institute (NCI), AstraZeneca. By stage, Mississippi trials break down as Phase 1 (2), Phase 2 (13), Phase 3 (32), Phase 4 (3).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Frequently Asked Questions — Clinical Trials in Mississippi